1Y Target$34.19Near-term target
5Y Target$47.88Compound horizon
10Y Target$70.38Long-dated conviction
FCF—TTM—FCF not applicable for this sector (bank / insurer / REIT) or data unavailable
Rev+230.1%TTM YoYARevenue +230.1% — hypergrowth, top decile
D/E0.08AD/E 0.08 — essentially debt-free, pristine balance sheet
P/E11.6xA-P/E 11.6 — cheap relative to market and most sectors
PEG0.05proxyAPEG 0.05 — exceptional; paying well under fair value for growth · PEG proxy: P/E ÷ revenue growth % (true PEG requires forward EPS estimates, not in Finnhub free tier).
Why now
Banking · market cap $8.6b. 9% off the 52-week high of $32.70. Revenue growing +230% — in hypergrowth territory. PEG 0.05 — paying under fair value for the growth rate.
Moat
Net margin 19% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. ROE 10% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere. Financial moat — scale of deposit base / underwriting franchise plus regulatory capital advantages. The largest players compound book value through cycles that erase smaller competitors.
Risk
Balance-sheet financial — book value, net interest margin, and credit loss provisions are the lever points; a rates regime change or a deterioration in the loan book moves the stock more than EPS does.
Horizon
1-3 yr $34.19 (structural (no analyst coverage)) — fundamentals + valuation re-rating. 5 yr $47.88 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $70.38 if current growth sustains into durable earnings power.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See
terms and
methodology for full disclosures.